Literature DB >> 6381046

The great cephalosporin wars.

M S Cohen.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6381046     DOI: 10.1007/bf02014873

Source DB:  PubMed          Journal:  Eur J Clin Microbiol        ISSN: 0722-2211            Impact factor:   3.267


× No keyword cloud information.
  12 in total

1.  Development of meningitis during cephalothin therapy.

Authors:  R J Mangi; R S Kundargi; R Quintiliani; V T Andriole
Journal:  Ann Intern Med       Date:  1973-03       Impact factor: 25.391

2.  Antibiotics: the medium is the message.

Authors:  D M Musher
Journal:  Rev Infect Dis       Date:  1983 Jul-Aug

3.  Bactericidal activities of new beta-lactam antibiotics against Bacteroides fragilis.

Authors:  P K Yu; J A Washington
Journal:  Antimicrob Agents Chemother       Date:  1983-07       Impact factor: 5.191

4.  Adverse effects of new cephalosporins.

Authors:  S G Jenkinson
Journal:  Ann Intern Med       Date:  1983-03       Impact factor: 25.391

5.  Cefotaxime failure in group A streptococcal meningitis.

Authors:  P B Iannini; M J Kunkel
Journal:  JAMA       Date:  1982-10-15       Impact factor: 56.272

6.  Novel resistance selected by the new expanded-spectrum cephalosporins: a concern.

Authors:  C C Sanders
Journal:  J Infect Dis       Date:  1983-03       Impact factor: 5.226

Review 7.  The new beta-lactamase-stable cephalosporins.

Authors:  H C Neu
Journal:  Ann Intern Med       Date:  1982-09       Impact factor: 25.391

8.  Comparative in vitro activities of third-generation cephalosporins.

Authors:  R J Fass
Journal:  Arch Intern Med       Date:  1983-09

9.  Clinical evaluation of moxalactam: evidence of decreased efficacy in gram-positive aerobic infections.

Authors:  W Salzer; P S Pegram; C E McCall
Journal:  Antimicrob Agents Chemother       Date:  1983-04       Impact factor: 5.191

10.  Clinical use of the new beta-lactam antimicrobial drugs. Practical considerations for physicians, microbiology laboratories, pharmacists, and formulary committees.

Authors:  G F Brooks; S L Barriere
Journal:  Ann Intern Med       Date:  1983-04       Impact factor: 25.391

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.